Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IBIT vs MRNA✓SelectedUSD · MRNAIBIT vs MRNA performance historyLatest closeAs of-5.52%11/16
Stock and ETF performance explorer

IBIT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+38.2%
MRNA return
+98.2%
Excess return
-60.1%
Maximum drawdown
-53.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.5%-3.6%-1.9%-5.3%
7D-13.1%-20.0%+6.9%-11.9%
30D-20.3%-1.3%-19.0%-20.3%
3M+3.3%+240.0%-236.7%-9.0%
6M-17.9%+339.0%-356.9%-30.8%
YTD-25.9%+630.0%-655.9%-42.0%
1Y-31.2%+769.1%-800.3%-47.5%
All+38.2%+98.2%-60.1%+21.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling